Genome Economy

The Human Genome Project's discovery1 that the human body runs on an instruction manual of a mere 35,000 or so genes--compared to the worm's 19,000, the fruit fly's 13,000, and the tiny mustard relative Arabidopsis thaliana's 25,000--placed humanity on an even playing field with these other, supposedly simpler, organisms. It was a humbling experience, but humility quickly gave way to awe with the realization that the human genome might encode 100,000 to 200,000 proteins. Scientists base this num

Written byRicki Lewis
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

The disparity between gene and protein number challenges the classic 'one gene/one polypeptide' paradigm that has governed molecular biology for decades. Still, some researchers decided long ago that the paradigm was simplistic--to them news of the paucity of protein-encoding genes in the human genome wasn't surprising. "It seems that gene number is not as important as gene interactions," says Xiangyin Kong, an investigator at the Shanghai Research Center of Biotechnology at the Chinese Academy of Sciences.

The human genome sequence, particularly its repetitive nature, also rejuvenated interest in genetic mechanisms that underlie the evolution of biological complexity. Eukaryotes, with their myriad cell organelles and other compartments, are far more complex than the evolutionarily much older bacteria and archaeans. How does a large eukaryotic organism like a plant or animal extract the most information from its genome? Recent research reveals a number of strategies for genome economy, and some are indeed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies